Published in Medical Letter on the CDC and FDA, February 18th, 2001
Cancidas is the first approved drug in a class of anti-fungal agents called echinocandins, which are believed to work by disrupting the creation of fungal cell walls.
Invasive aspergillosis is a term used to describe a group of fungal infections caused by the fungus Aspergillus. Most healthy individuals are unaffected by this common fungus; however exposed individuals with weakened or abnormal...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.